Elevance Health, Inc. $ELV Stock Position Lifted by Private Wealth Asset Management LLC

Private Wealth Asset Management LLC increased its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 185.9% in the third quarter, Holdings Channel.com reports. The firm owned 2,407 shares of the company’s stock after buying an additional 1,565 shares during the quarter. Private Wealth Asset Management LLC’s holdings in Elevance Health were worth $1,024,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Activest Wealth Management increased its stake in shares of Elevance Health by 146.2% in the third quarter. Activest Wealth Management now owns 64 shares of the company’s stock valued at $25,000 after buying an additional 38 shares during the period. Kilter Group LLC bought a new stake in Elevance Health during the 2nd quarter worth approximately $28,000. Elevation Wealth Partners LLC increased its position in Elevance Health by 600.0% in the 2nd quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock valued at $41,000 after acquiring an additional 90 shares during the period. Tacita Capital Inc acquired a new position in Elevance Health in the 2nd quarter valued at approximately $44,000. Finally, Danske Bank A S acquired a new position in Elevance Health in the 2nd quarter valued at approximately $44,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Mark Kaye sold 10,584 shares of the company’s stock in a transaction that occurred on Thursday, October 22nd. The stock was sold at an average price of $440.13, for a total transaction of $4,658,335.92. Following the transaction, the chief financial officer directly owned 19,919 shares of the company’s stock, valued at approximately $8,766,949.47. This represents a 34.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Ratnakar Lavu sold 1,300 shares of the company’s stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $440.00, for a total value of $572,000.00. Following the transaction, the executive vice president directly owned 14,849 shares in the company, valued at $6,533,560. The trade was a 8.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

ELV has been the subject of several analyst reports. Wall Street Zen raised shares of Elevance Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. The Goldman Sachs Group reissued a “neutral” rating and issued a $451.00 price objective on shares of Elevance Health in a research note on Friday, October 23rd. Robert W. Baird increased their price objective on Elevance Health from $393.00 to $406.00 and gave the company a “neutral” rating in a report on Thursday, October 22nd. Wells Fargo & Company raised their target price on Elevance Health from $473.00 to $492.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 27th. Finally, Barclays raised their target price on Elevance Health from $469.00 to $472.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Sixteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $458.91.

Check Out Our Latest Report on ELV

Elevance Health Price Performance

Elevance Health stock opened at $394.40 on Friday. The stock has a market capitalization of $85.21 billion, a price-to-earnings ratio of 16.82, a PEG ratio of 1.82 and a beta of 0.63. Elevance Health, Inc. has a 52-week low of $274.84 and a 52-week high of $450.69. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.47 and a current ratio of 1.47. The stock’s 50 day moving average price is $415.92 and its two-hundred day moving average price is $376.97.

Elevance Health (NYSE:ELV – Get Free Report) last released its quarterly earnings data on Wednesday, October 21st. The company reported $6.99 earnings per share for the quarter, beating the consensus estimate of $4.71 by $2.28. Elevance Health had a net margin of 2.55% and a return on equity of 14.97%. The company had revenue of $50.44 billion during the quarter, compared to analyst estimates of $49.28 billion. During the same quarter in the previous year, the business posted $6.03 EPS. Elevance Health’s revenue for the quarter was up .7% compared to the same quarter last year. On average, equities analysts predict that Elevance Health, Inc. will post 29.16 earnings per share for the current year.

Elevance Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Shareholders of record on Friday, December 4th will be issued a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Friday, December 4th. Elevance Health’s dividend payout ratio (DPR) is presently 29.34%.

Elevance Health Profile

(Free Report)

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

Featured Articles

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).

Institutional Ownership by Quarter for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.